CSL Limited

About CSL Limited

CSL Limited is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines. Founded in 1916, the company has grown to become a leader in the field of biopharmaceuticals, with a strong commitment to improving the lives of patients worldwide.

With its headquarters in Melbourne, Australia, CSL operates in over 35 countries and employs more than 25,000 people globally. The company focuses on the research, development, and manufacturing of a wide range of products, including therapies for bleeding disorders, immunodeficiencies, and hereditary angioedema.

CSL's vision is to be a global leader in biotechnology, driven by a passion for innovation and a commitment to quality. The company invests heavily in research and development, with a significant portion of its revenue allocated to advancing scientific knowledge and developing new therapies.

In addition to its biotherapeutic products, CSL is also known for its expertise in vaccine development, particularly in response to seasonal and pandemic influenza. The company collaborates with various health organizations and governments to ensure the availability of effective vaccines.

CSL Limited is dedicated to sustainability and corporate responsibility, striving to make a positive impact on the communities it serves. The company actively engages in initiatives that promote health, education, and environmental stewardship.

Overall, CSL Limited stands out as a pioneering force in the biotechnology industry, committed to enhancing patient outcomes through innovative solutions and a steadfast dedication to excellence.